TIME LISTED ABOVE IS IN CDT
This session will provide information on currently available products, focusing mainly on the differences between levonorgestrel and ulipristal acetate. An algorithm will be reviewed regarding the management of women requesting EC, especially regarding differences in management based upon body weight. FDA regulations on the subject of provision of EC products with and without prescription will be reviewed.
At the completion of this workshop, participants will be able to:
- Describe 3 visual characteristics seen in lichen sclerosis.
- Describe VIN lesions by color, surface, and margination.